[HTML][HTML] Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients
On the 30 th of January 2020, the World Health Organization fired up the sirens against a
fast spreading infectious disease caused by a newly discovered Severe Acute Respiratory …
fast spreading infectious disease caused by a newly discovered Severe Acute Respiratory …
Applications and strategies in nanodiagnosis and nanotherapy in lung cancer
Lung cancer is the second most common cancer and the leading cause of death in both men
and women in the world. Lung cancer is heterogeneous in nature and diagnosis is often at …
and women in the world. Lung cancer is heterogeneous in nature and diagnosis is often at …
Recent applications and strategies in nanotechnology for lung diseases
W Zhong, X Zhang, Y Zeng, D Lin, J Wu - Nano Research, 2021 - Springer
Lung diseases, including COVID-19 and lung cancers, is a huge threat to human health.
However, for the treatment and diagnosis of various lung diseases, such as pneumonia …
However, for the treatment and diagnosis of various lung diseases, such as pneumonia …
Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer
This study was aimed at developing a nanoparticle strategy to overcome acquired
resistance against erlotinib in non-small cell lung cancer (NSCLC). To load erlotinib on …
resistance against erlotinib in non-small cell lung cancer (NSCLC). To load erlotinib on …
Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases
Pulmonary diseases pose an immense threat to global health. Several nanotherapeutics-
based approaches aimed to tackle pulmonary ailments in recent years. The current …
based approaches aimed to tackle pulmonary ailments in recent years. The current …
[HTML][HTML] Scalable production and in vitro efficacy of inhaled erlotinib nanoemulsion for enhanced efficacy in non-small cell lung cancer (NSCLC)
Non-small cell lung cancer (NSCLC) is a global concern as one of the leading causes of
cancer deaths. The treatment options for NSCLC are limited to systemic chemotherapy …
cancer deaths. The treatment options for NSCLC are limited to systemic chemotherapy …
Enhanced stability and oral bioavailability of erlotinib by solid self nano emulsifying drug delivery systems
The present investigation demonstrates the preparation of solid self nanoemulsfying drug
delivery system (sSNEDDS) to enhance stability and bioavailability of Erlotinib (ERL) via the …
delivery system (sSNEDDS) to enhance stability and bioavailability of Erlotinib (ERL) via the …
Nanostructured lipid carriers-based drug delivery for treating various lung diseases: A State‐of‐the‐Art Review
TS Patil, AS Deshpande - International journal of pharmaceutics, 2018 - Elsevier
According to the list published by the WHO for global top ten causes of death, lung diseases
contribute nearly one-third of the total mortality. The current treatment on lung diseases …
contribute nearly one-third of the total mortality. The current treatment on lung diseases …
Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver
Erlotinib (ERL), a tyrosine kinase inhibitor approved for therapeutic use in non-small cell
lung cancer is further researched for eventual liver cancer treatment. However, conventional …
lung cancer is further researched for eventual liver cancer treatment. However, conventional …
Current advances in drug delivery of nanoparticles for respiratory disease treatment
BRC de Menezes, KF Rodrigues… - Journal of Materials …, 2021 - pubs.rsc.org
Cases of respiratory diseases have been increasing around the world, affecting the health
and quality of life of millions of people every year. Chronic respiratory diseases (CRDs) and …
and quality of life of millions of people every year. Chronic respiratory diseases (CRDs) and …